NBD AI Bulletin -- Tonghua Dongbao Pharmaceutical Co,Ltd (SH 600867, close price: 10.71 yuan) on September 17 announced that the Company's actual controller was changed to Li Yikui from Li Yikui and Wang Dianduo.
The 2021 semiannual report shows that the main business of Tonghua Dongbao Pharmaceutical is the pharmaceutical industry, real estate industry, building materials industry, accounting for 97.93%, 1.21%, 0.02% of revenue, respectively.
(By Gao Han)
Disclaimer: The content and data of this article are for reference only and do not constitute investment advice. Please verify before use. Any action you take upon the information on this website is at your own risk.